Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013 (2013), Article ID 735489, 5 pages
http://dx.doi.org/10.1155/2013/735489
Case Report

Monitoring Patient Improvement Parameters following Pasireotide Treatment in Cushing’s Disease

1Northwest Pituitary Center, 3303 SW Bond Avenue, Portland, OR 97239, USA
2Department of Neurosurgery, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
3Department of Internal Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA

Received 2 August 2013; Accepted 18 September 2013

Academic Editors: M. Demura, O. Isozaki, and M. P. Kane

Copyright © 2013 Chris Yedinak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Arnaldi, A. Angeli, A. B. Atkinson et al., “Diagnosis and complications of Cushing's syndrome: a consensus statement,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 12, pp. 5593–5602, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Feelders, S. J. Pulgar, A. Kempel, and A. M. Pereira, “The burden of Cushing's disease: clinical and health-related quality of life aspects,” European Journal of Endocrinology, vol. 167, no. 3, pp. 311–326, 2012. View at Publisher · View at Google Scholar
  3. J. Newell-Price, X. Bertagna, A. B. Grossman, and L. K. Nieman, “Cushing's syndrome,” The Lancet, vol. 367, no. 9522, pp. 1605–1617, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. G. Patil, D. M. Prevedello, S. P. Lad et al., “Late recurrences of Cushing's disease after initial successful transsphenoidal surgery,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 2, pp. 358–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Etxabe and J. A. Vazquez, “Morbidity and mortality in Cushing's disease: an epidemiological approach,” Clinical Endocrinology, vol. 40, no. 4, pp. 479–484, 1994. View at Google Scholar · View at Scopus
  6. J. Lindholm, S. Juul, J. O. Jørgensen et al., “Incidence and late prognosis of Cushing's syndrome: a population-based study,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 1, pp. 117–123, 2001. View at Publisher · View at Google Scholar
  7. M. Fleseriu and S. Petersenn, “Medical management of Cushing's disease: what is the future?” Pituitary, vol. 15, no. 3, pp. 330–341, 2012. View at Publisher · View at Google Scholar
  8. L. K. Nieman, “Medical therapy of Cushing's disease,” Pituitary, vol. 5, no. 2, pp. 77–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Castinetti, I. Morange, P. Jaquet, B. Conte-Devolx, and T. Brue, “Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease,” European Journal of Endocrinology, vol. 158, no. 1, pp. 91–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Fleseriu, B. M. Biller, J. W. Findling et al., “Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 6, pp. 2039–2049, 2012. View at Publisher · View at Google Scholar
  11. A. Colao, S. Petersenn, J. Newell-Price et al., “A 12-month phase 3 study of pasireotide in Cushing's disease,” The New England Journal of Medicine, vol. 366, no. 10, pp. 914–924, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. B. Atkinson, A. Kennedy, M. I. Wiggam, D. R. McCance, and B. Sheridan, “Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance,” Clinical Endocrinology, vol. 63, no. 5, pp. 549–559, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Novartis Pharma AG, “Signifor Summary of Product Characteristics,” June 2013, http://www.signifor.com/european-product-characteristics.jsp.
  14. R. R. Henry, S. Mudaliar, K. Wetli-Hermosillo et al., “Mechanism and management of hyperglycemia associated with pasireotide: results from studies in healthy volunteers,” Endocrine Reviews, vol. 32, no. 3, article P3-274, 2011. View at Google Scholar